Robert W. Bina

Robert W. Bina

Auto-generated profile, based on publicly available information

Robert W. Bina

College of Medicine, University of Arizona Phoenix

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in World Neurosurgery
Verified
Journal Article
Open access
JKJames Kelbert
James Kelbert
KNKristin Nosova
Kristin Nosova
AKAshley Kern
Ashley Kern
RRRachel Russell
Rachel Russell
APAnnie Pico
Annie Pico
RBRobert W. Bina
Robert W. Bina
Idiopathic normal pressure hydrocephalus is classically recognized by the triad of gait disturbance, cognitive dysfunction, and urinary incontinence. Since ventricular shunting may be affected by valve type, we conducted a meta-analysis to assess the relationship between valve characteristics and outcomes. English language studies that reported valve types, outcomes, and associated complications were included. Data were extracted and analyzed using R, version 4.3.2. Thirteen studies were included. With gravitational valves, meta-analysis yielded 0.04 [0.02, 0.07] for subdural effusions (SDEs), 0.00 [0.00, 0.00] for surgical SDEs, 0.06 [0.03, 0.09] for proximal revisions, and 0.06 [0.03, 0.09] for distal. With differential pressure valves (DPVs) with antisiphon control, meta-analysis showed an incidence of 0.10 [0.07, 0.13] for SDEs, 0.02 [0.01, 0.04] for surgical SDEs, 0.03 [0.01, 0.05] for proximal and 0.04 [0.02, 0.07] for distal revisions. With DPVs without antisiphon control, there was an incidence of 0.17 [0.11, 0.23] for SDEs, 0.11 [0.06, 0.19] for surgical SDEs, 0.00 [0.00, 0.02] for proximal shunt revisions, and 0.05 [0.02, 0.10] for distal shunt revisions. With flow regulated valves, there was an incidence of 0.05 [0.01, 0.12] for SDEs, 0.01 [0.00, 0.05] for surgical SDEs, 0.06 [0.02, 0.11] for proximal revisions, and 0.01 [0.00, 0.05] for distal. Gravitational valves and NPVs are associated with fewer SDEs while DPVs with and without ASDs are associated with more while there were no differences in proximal or distal revisions.

1 January 2019 in Stereotactic and Functional Neurosurgery
Verified
Journal Article
Closed access
PDF file
WKWillard Kasoff
Willard Kasoff
RBRobert W. Bina
Robert W. Bina
Background: Peripheral neurostimulation (PNS) for medically refractory trigeminal and craniofacial pain is an emerging alternative to traditional surgical approaches. Technical problems with craniofacial PNS have included electrode migration and erosion, limiting the utility and cost-effectiveness of this procedure. Objective: To review our institutional surgical technique for trigeminal PNS implantation, focusing on a novel technique for electrode anchoring. Methods: Consecutive cases of permanent craniofacial PNS placement by a single surgeon over 36 months were reviewed for surgical technique and technical outcomes. Electrodes were placed percutaneously with open anchoring to the pericranium at a separate parietal incision. Results: Sixteen systems (53 electrodes) were implanted in 14 patients. Median follow-up was 13 months (range, 5–29 months). Electrode placement was successful in all cases with no intraoperative complications. There was 1 lead migration (6.3% per patient; 1.8% per lead) and no cases of erosion. Two patients (14.3%) required explant for infection, 1 of whom was successfully reimplanted. Three patients (21.4%) underwent surgical revision other than for infection. Conclusions: We present an improved method for craniofacial PNS surgery which introduces a separate incision for electrode anchoring at the parietal boss. This technique simplifies the procedure and greatly reduces rates of erosion and migration, improving patient comfort and satisfaction.

1 July 2020 in World Neurosurgery
Verified
Journal Article
Closed access
RPRyan Palsma
Ryan Palsma
NGNicholas Gravbrot
Nicholas Gravbrot
RBRobert Bina
Robert Bina
MAManas Agastya
Manas Agastya
WKWillard S. Kasoff
Willard S. Kasoff

27 July 2026 in Journal of Neurosurgery: Case Lessons
Verified
Journal Article
Open access
PDF file
RZRose Valerie Zach
Rose Valerie Zach
JKJames Kelbert
James Kelbert
RBRobert W. Bina
Robert W. Bina
VVVimala Vajjala
Vimala Vajjala
GMGanesh Murthy
Ganesh Murthy
BACKGROUND: Neuromodulation, including deep brain stimulation (DBS), is a treatment option for patients with medically intractable epilepsy who do not meet candidacy for resective surgery. DBS of the anterior nucleus of the thalamus (ANT) has been FDA approved for focal epilepsy, and stimulation of the centromedian nucleus of the thalamus (CMT) is increasingly being explored for generalized epilepsies including juvenile myoclonic epilepsy (JME). The authors present the case of a patient with JME and medically intractable seizures who underwent bilateral, sequential ANT and CMT DBS implantation. OBSERVATIONS: This case describes a 51-year-old woman with medically intractable JME in whom adequate trials of more than 10 antiseizure medications and prior vagus nerve stimulation failed. She underwent bilateral ANT DBS, which reduced her generalized tonic-clonic seizures but did not improve her myoclonic jerks. Owing to persistent disability from daily myoclonus, she later underwent bilateral CMT DBS. Following CMT stimulation, she experienced rare myoclonic jerks. At 7 months postoperatively, her status remained Engel class IIb with sustained functional improvement. LESSONS: This case highlights the complementary roles of ANT and CMT stimulation in modulating distinct thalamocortical pathways. Although CMT DBS has been described in patients with generalized epilepsy, this case demonstrates a meaningful reduction specifically in disabling myoclonic jerks that previously resulted in falls and dropped objects. https://thejns.org/doi/10.3171/CASE251033